Joerg Holenz

Joerg Holenz is an accomplished pharmaceutical executive with extensive experience in research and development, particularly in neuroscience and pain management. Currently serving as the Chief Scientific Officer and Head of Research and Development at BIAL since November 2021, Joerg is also a Board Member at BIAL Biotech. Previously held positions include Senior Vice President at Grünenthal Group, where Joerg reorganized the R&D function, and Senior Director at GSK, where Joerg led a virtual Discovery Performance Unit focused on CNS treatments. Joerg's earlier roles at AstraZeneca included Director of Discovery and Preclinical Sciences, delivering leading first-in-class Alzheimer’s treatments, and positions in lead optimization and medicinal chemistry. Joerg began a career in academia with a Ph.D. in Organic and Medicinal Chemistry from The Julius Maximilians University of Würzburg and has contributed significantly to the development of novel therapies throughout a distinguished career spanning multiple leading pharmaceutical companies.